Price to Book Value (P/BV)
since 2005
Beginner level
Calculation
Bristol-Myers Squibb Co., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Bristol-Myers Squibb Company shareholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 2.80 | = | 63.97 | ÷ | 22.86 | 22.86 | = | 51,598 | ÷ | 2,257,510,796 | |
| Dec 31, 2018 | 5.89 | = | 50.65 | ÷ | 8.59 | 8.59 | = | 14,031 | ÷ | 1,632,675,877 | |
| Dec 31, 2017 | 8.88 | = | 63.87 | ÷ | 7.19 | 7.19 | = | 11,741 | ÷ | 1,632,582,502 | |
| Dec 31, 2016 | 5.66 | = | 54.78 | ÷ | 9.67 | 9.67 | = | 16,177 | ÷ | 1,672,715,340 | |
| Dec 31, 2015 | 7.04 | = | 60.20 | ÷ | 8.55 | 8.55 | = | 14,266 | ÷ | 1,669,459,090 | |
| Dec 31, 2014 | 6.72 | = | 60.04 | ÷ | 8.94 | 8.94 | = | 14,852 | ÷ | 1,662,118,446 | |
| Dec 31, 2013 | 5.92 | = | 54.37 | ÷ | 9.18 | 9.18 | = | 15,154 | ÷ | 1,650,232,566 | |
| Dec 31, 2012 | 4.40 | = | 36.58 | ÷ | 8.32 | 8.32 | = | 13,623 | ÷ | 1,637,354,662 | |
| Dec 31, 2011 | 3.50 | = | 33.12 | ÷ | 9.45 | 9.45 | = | 15,956 | ÷ | 1,688,107,071 | |
| Dec 31, 2010 | 2.76 | = | 25.49 | ÷ | 9.23 | 9.23 | = | 15,713 | ÷ | 1,702,427,438 | |
| Dec 31, 2009 | 2.88 | = | 24.95 | ÷ | 8.66 | 8.66 | = | 14,843 | ÷ | 1,714,140,539 | |
| Dec 31, 2008 | 3.29 | = | 20.37 | ÷ | 6.18 | 6.18 | = | 12,241 | ÷ | 1,979,509,306 | |
| Dec 31, 2007 | 4.22 | = | 22.53 | ÷ | 5.34 | 5.34 | = | 10,562 | ÷ | 1,979,387,706 | |
| Dec 31, 2006 | 5.50 | = | 27.19 | ÷ | 4.95 | 4.95 | = | 9,991 | ÷ | 2,019,481,440 | |
| Dec 31, 2005 | 4.00 | = | 22.91 | ÷ | 5.72 | 5.72 | = | 11,208 | ÷ | 1,959,073,035 |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Bristol-Myers Squibb Co.’s Annual Report.
Comparison to Competitors
Bristol-Myers Squibb Co., P/BV, long-term trends, comparison to competitors
| Bristol-Myers Squibb Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 2.80 | 4.96 | — | 1.12 | 13.84 | 4.40 | 51.67 | 3.93 | 9,432.47 | 6.61 | 7.83 | 3.00 | 3.79 | 10.23 | 25.42 |
| Dec 31, 2018 | 5.89 | 4.38 | — | 0.71 | 9.41 | 5.03 | 12.87 | 3.89 | 11.43 | 6.08 | 7.79 | 3.80 | 5.07 | 10.68 | 18.74 |
| Dec 31, 2017 | 8.88 | 3.40 | 36.95 | 0.73 | 5.02 | 5.80 | 7.33 | 5.15 | 11.79 | 5.79 | 4.30 | 2.94 | 5.66 | 20.14 | 21.52 |
| Dec 31, 2016 | 5.66 | 3.76 | 21.24 | 1.08 | 4.14 | 4.70 | 6.33 | 4.88 | 10.95 | 4.72 | 4.51 | 3.40 | 8.58 | 18.42 | 17.46 |
| Dec 31, 2015 | 7.04 | 2.68 | 22.17 | 1.54 | 3.94 | 6.31 | 5.51 | 6.59 | 12.50 | 4.07 | 3.15 | 2.84 | 10.53 | 22.38 | 19.72 |
| Dec 31, 2014 | 6.72 | 3.32 | 56.09 | 2.67 | 4.59 | 8.49 | 5.14 | 10.08 | 19.53 | 4.01 | 3.42 | 2.95 | 16.22 | 25.60 | 17.61 |
| Dec 31, 2013 | 5.92 | 2.38 | 18.05 | 4.11 | 4.30 | 8.25 | 3.69 | 11.36 | 14.25 | 3.50 | 3.35 | 2.69 | 16.74 | 14.77 | 15.56 |
| Dec 31, 2012 | 4.40 | 2.06 | 18.06 | 2.84 | 3.57 | 5.34 | 4.15 | 7.01 | 4.58 | 3.29 | 2.44 | 2.42 | 12.91 | 10.08 | 4.15 |
| Dec 31, 2011 | 3.50 | 3.61 | — | 2.15 | 2.83 | 4.53 | 3.35 | 5.08 | 5.83 | 3.13 | 2.14 | 1.95 | 19.19 | 10.05 | — |
| Dec 31, 2010 | 2.76 | 3.24 | — | 2.10 | 2.04 | 2.94 | 3.21 | 5.29 | 7.40 | 2.88 | 1.85 | 1.75 | 6.42 | 16.16 | — |
| Dec 31, 2009 | 2.88 | 3.69 | — | 1.64 | 2.46 | 2.34 | 4.17 | 6.74 | 5.06 | 3.45 | 1.97 | 1.57 | 5.49 | 7.45 | — |
| Dec 31, 2008 | 3.29 | 4.78 | — | 1.44 | 2.48 | 2.69 | 5.01 | 9.83 | 4.59 | 3.56 | 2.72 | 1.44 | 2.94 | 21.09 | — |
| Dec 31, 2007 | 4.22 | 4.83 | — | 1.58 | 2.77 | 3.38 | 4.16 | 11.76 | 10.05 | 4.17 | 5.38 | 2.32 | 3.24 | 8.92 | — |
| Dec 31, 2006 | 5.50 | 5.88 | — | 1.57 | 3.96 | 2.25 | 5.43 | 18.07 | 8.16 | 4.78 | 5.45 | 2.49 | 5.77 | 7.52 | — |
| Dec 31, 2005 | 4.00 | 4.69 | — | 1.56 | 4.26 | 2.27 | 5.85 | 9.18 | 14.56 | 4.66 | 4.30 | 2.94 | 8.16 | 18.12 | — |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Bristol-Myers Squibb Co., P/BV, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Bristol-Myers Squibb Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 2.80 | 128.27 |
| Dec 31, 2018 | 5.89 | 5.38 |
| Dec 31, 2017 | 8.88 | 4.57 |
| Dec 31, 2016 | 5.66 | 4.13 |
| Dec 31, 2015 | 7.04 | 3.88 |
| Dec 31, 2014 | 6.72 | 4.75 |
| Dec 31, 2013 | 5.92 | 4.22 |
| Dec 31, 2012 | 4.40 | 3.31 |
| Dec 31, 2011 | 3.50 | 2.78 |
| Dec 31, 2010 | 2.76 | 2.40 |
| Dec 31, 2009 | 2.88 | 2.55 |
| Dec 31, 2008 | 3.29 | 2.97 |
| Dec 31, 2007 | 4.22 | 3.71 |
| Dec 31, 2006 | 5.50 | 4.09 |
| Dec 31, 2005 | 4.00 | 4.00 |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Industry (Health Care)
Bristol-Myers Squibb Co., P/BV, long-term trends, comparison to industry (health care)
| Bristol-Myers Squibb Co. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 2.80 | 80.20 |
| Dec 31, 2018 | 5.89 | 4.80 |
| Dec 31, 2017 | 8.88 | 4.28 |
| Dec 31, 2016 | 5.66 | 3.86 |
| Dec 31, 2015 | 7.04 | 3.54 |
| Dec 31, 2014 | 6.72 | 4.34 |
| Dec 31, 2013 | 5.92 | 3.82 |
| Dec 31, 2012 | 4.40 | 3.03 |
| Dec 31, 2011 | 3.50 | 2.60 |
| Dec 31, 2010 | 2.76 | 2.34 |
| Dec 31, 2009 | 2.88 | 2.43 |
| Dec 31, 2008 | 3.29 | 2.71 |
| Dec 31, 2007 | 4.22 | 3.51 |
| Dec 31, 2006 | 5.50 | 3.84 |
| Dec 31, 2005 | 4.00 | 4.15 |
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).